In the second part of this Manufacturing Chemist article series, our COO, Grant Boldt discusses benefits of single-stranded DNA for gene therapy development and the application of self-folding nanocarriers for gene delivery and specific cell and tissue targeting functionalization. The series closes with a forward-thinking review of future perspectives and challenges.
Discover how single-stranded DNA is shaping the future of precision medicine — read the full article: Opening New Doors to Precision Medicine
Find PART ONE by clicking here. Feel free to reach out at info@gxstrands.com or schedule a meeting to start a conversation about our single-stranded DNA manufacturing capabilities.
